A multicenter, retrospective study assessing the real world outcomes of axi-cel CAR T-cell therapy for r/r aggressive B-cell lymphoma
Latest Information Update: 30 Nov 2019
At a glance
- Drugs Axicabtagene ciloleucel (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Pharmacodynamics; Therapeutic Use
Most Recent Events
- 06 Nov 2019 Results released at the 61st Annual Meeting and Exposition of the American Society of Hematology (ASH-Hem 2019).
- 04 Feb 2019 New trial record